156 related articles for article (PubMed ID: 7645559)
1. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat.
Gile RD; Cowley BD; Gattone VH; O'Donnell MP; Swan SK; Grantham JJ
Am J Kidney Dis; 1995 Sep; 26(3):501-7. PubMed ID: 7645559
[TBL] [Abstract][Full Text] [Related]
2. The effect of paclitaxel on the progression of polycystic kidney disease in rodents.
Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ
Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221
[TBL] [Abstract][Full Text] [Related]
3. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.
Pey R; Bach J; Schieren G; Gretz N; Hafner M
In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866
[TBL] [Abstract][Full Text] [Related]
4. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.
Tao Y; Kim J; Faubel S; Wu JC; Falk SA; Schrier RW; Edelstein CL
Proc Natl Acad Sci U S A; 2005 May; 102(19):6954-9. PubMed ID: 15863619
[TBL] [Abstract][Full Text] [Related]
5. Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease.
Ramasubbu K; Gretz N; Bachmann S
J Am Soc Nephrol; 1998 Jun; 9(6):937-45. PubMed ID: 9621276
[TBL] [Abstract][Full Text] [Related]
6. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
[TBL] [Abstract][Full Text] [Related]
7. Methylprednisolone retards the progression of inherited polycystic kidney disease in rodents.
Gattone VH; Cowley BD; Barash BD; Nagao S; Takahashi H; Yamaguchi T; Grantham JJ
Am J Kidney Dis; 1995 Feb; 25(2):302-13. PubMed ID: 7847359
[TBL] [Abstract][Full Text] [Related]
8. Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats.
Wang X; Zhang S; Liu Y; Spichtig D; Kapoor S; Koepsell H; Mohebbi N; Segerer S; Serra AL; Rodriguez D; Devuyst O; Mei C; Wüthrich RP
Kidney Int; 2013 Nov; 84(5):962-8. PubMed ID: 23715121
[TBL] [Abstract][Full Text] [Related]
9. Modification of disease progression in rats with inherited polycystic kidney disease.
Cowley BD; Grantham JJ; Muessel MJ; Kraybill AL; Gattone VH
Am J Kidney Dis; 1996 Jun; 27(6):865-79. PubMed ID: 8651252
[TBL] [Abstract][Full Text] [Related]
10. Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats.
Aukema HM; Housini I
Kidney Int; 2001 Jan; 59(1):52-61. PubMed ID: 11135057
[TBL] [Abstract][Full Text] [Related]
11. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
Banković-Calić N; Ogbori MR; Nicman E
Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation.
Wu M; Gu J; Mei S; Xu D; Jing Y; Yao Q; Chen M; Yang M; Chen S; Yang B; Qi N; Hu H; Wüthrich RP; Mei C
Nephrol Dial Transplant; 2016 Nov; 31(11):1826-1834. PubMed ID: 27190325
[TBL] [Abstract][Full Text] [Related]
13. Renal concentration of alpha-tocopherol: dependence on gender and lack of effect on polycystic kidney disease in Han:SPRD rats.
Torres VE; Bengal RJ; Nickander KK; Grande JP; Low PA
Am J Kidney Dis; 1998 Apr; 31(4):687-93. PubMed ID: 9531187
[TBL] [Abstract][Full Text] [Related]
14. Gender-dependent effect of L-NAME on polycystic kidney disease in Han:SPRD rats.
Yoshida I; Bengal R; Torres VE
Am J Kidney Dis; 2000 May; 35(5):930-6. PubMed ID: 10793029
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
[TBL] [Abstract][Full Text] [Related]
16. Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway.
Jing Y; Wu M; Zhang D; Chen D; Yang M; Mei S; He L; Gu J; Qi N; Fu L; Li L; Mei C
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F479-F486. PubMed ID: 29513074
[TBL] [Abstract][Full Text] [Related]
17. Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats.
Cowley BD; Rupp JC; Muessel MJ; Gattone VH
Am J Kidney Dis; 1997 Feb; 29(2):265-72. PubMed ID: 9016899
[TBL] [Abstract][Full Text] [Related]
18. Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender.
Ogborn MR; Nitschmann E; Bankovic-Calic N; Weiler HA; Aukema HM
Lipids; 2006 Dec; 41(12):1141-9. PubMed ID: 17269560
[TBL] [Abstract][Full Text] [Related]
19. EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats.
Torres VE; Sweeney WE; Wang X; Qian Q; Harris PC; Frost P; Avner ED
Kidney Int; 2003 Nov; 64(5):1573-9. PubMed ID: 14531789
[TBL] [Abstract][Full Text] [Related]
20. Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney disease.
Klawitter J; Zafar I; Klawitter J; Pennington AT; Klepacki J; Gitomer BY; Schrier RW; Christians U; Edelstein CL
BMC Nephrol; 2013 Jul; 14():165. PubMed ID: 23902712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
